SGP SpyGlass Pharma, Inc. - Common Stock
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$24.92
· of 52w range
· above low
· to high
$17.0652w low
$32.4452w high
Market Cap (MRQ)
$833M
EPS
$-17.98
your badges
52W Range
$17–$32
Analyst Rating
STRONG BUY
Price Target
$44
P/E
·
ROE
50.0%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
SGP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$24.92
Market Cap (MRQ)
$833M
EPS
$-17.98
ROE
50.0%
52W Range
$17–$32
SGP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-17.982024-12-31 → 2025-12-31
Free Cash Flow$-33M2025-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | SGP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 3.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | SGP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -57.3% | · | · | · | |
| ROE | 50.0% | · | · | · | |
| ROIC | 41.9% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | SGP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 25.1 | · | · | · | |
| Quick Ratio | 11.2 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-24.7%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | $-0.59 | $-0.52 | -13.6% | |
| March 31, 2026 | May 14, 2026 | $-0.69 | $-0.51 | -35.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| R&D Expense | $29M | $20M | |
| SG&A Expense | $12M | $7M | |
| Operating Expenses | $41M | $27M | |
| Operating Income | $-41M | $-27M | |
| Interest Income | $3M | $1M | |
| Other Non-op | $2M | $-2M | |
| Pretax Income | $-40M | $-29M | |
| Income Tax | $0 | $0 | |
| Net Income | $-40M | $-29M | |
| EPS (Basic) | $-17.98 | $-16.31 | |
| EPS (Diluted) | $-17.98 | $-16.31 | |
| Shares (Basic) | 2,217,104 | 1,788,211 | |
| Shares (Diluted) | 2,217,104 | 1,788,211 | |
| EBITDA | $-41M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $96M | $16M | |
| Prepaid Expense | $901.0K | $715.0K | |
| Current Assets | $109M | $17M | |
| PP&E (Net) | $2M | $2M | |
| PP&E (Gross) | $3M | $3M | |
| Accum. Depreciation | $1M | $543.0K | |
| Other Non-current Assets | $492.0K | $453.0K | |
| Total Assets | $116M | $23M | |
| Accounts Payable | $3M | $2M | |
| Current Liabilities | $9M | $8M | |
| Capital Leases | $2M | $3M | |
| Total Liabilities | $10M | $11M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $6M | $4M | |
| Retained Earnings | $-105M | $-65M | |
| Stockholders' Equity | $-99M | $-60M | |
| Liabilities + Equity | $116M | $23M | |
| Shares Outstanding | 2,203,620 | 2,196,423 |
Cash Flow
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $3M | $1M | |
| Deferred Tax | $-10M | $-7M | |
| Operating Cash Flow | $-33M | $-22M | |
| CapEx | $789.0K | $2M | |
| Investing Cash Flow | $-12M | $22M | |
| Stock Repurchased | $1M | $0 | |
| Net Stock Activity | $-1M | · | |
| Financing Cash Flow | $125M | $185.0K | |
| Net Change in Cash | $80M | $419.0K | |
| Taxes Paid | $1.0K | $18.0K | |
| Free Cash Flow | $-33M | · |
Profitability
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -57.3% | · | |
| ROE | 50.0% | · | |
| ROIC | 41.9% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 12.7 | · | |
| Quick Ratio | 11.2 | · |
Per Share
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Book Value / Share | $-44.85 | · | |
| Cash Flow / Share | $-14.75 | · | |
| Cash / Share | $43.73 | · | |
| EPS (TTM) | $-17.98 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Net Income TTM | $-40M | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| R&D Expense | $11M | $9M | · | $7M | $6M | |
| SG&A Expense | $11M | $7M | · | $2M | $1M | |
| Operating Expenses | $22M | $15M | · | $9M | $7M | |
| Operating Income | $-22M | $-15M | · | $-9M | $-7M | |
| Interest Income | $2M | $2M | · | $622.0K | $126.0K | |
| Other Non-op | $2M | $2M | · | $622.0K | $-1M | |
| Pretax Income | $-20M | $-14M | · | $-9M | $-9M | |
| Income Tax | $0 | $0 | · | $0 | $0 | |
| Net Income | $-20M | $-14M | · | $-9M | $-9M | |
| EPS (Basic) | $-0.59 | $-0.69 | · | $-3.81 | $-3.96 | |
| EPS (Diluted) | $-0.59 | $-0.69 | · | $-3.81 | $-3.96 | |
| Shares (Basic) | 33,439,543 | 19,927,848 | · | 2,277,521 | 2,229,637 | |
| Shares (Diluted) | 33,439,543 | 19,927,848 | · | 2,277,521 | 2,229,637 | |
| EBITDA | $-22M | $-15M | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $239M | $96M | · | · | |
| Prepaid Expense | $2M | $2M | $901.0K | · | · | |
| Current Assets | $236M | $253M | $109M | · | · | |
| PP&E (Net) | $5M | $3M | $2M | · | · | |
| PP&E (Gross) | $7M | $4M | $3M | · | · | |
| Accum. Depreciation | $2M | $1M | $1M | · | · | |
| Other Non-current Assets | $759.0K | $789.0K | $492.0K | · | · | |
| Total Assets | $243M | $258M | $116M | · | · | |
| Accounts Payable | $4M | $4M | $3M | · | · | |
| Current Liabilities | $9M | $7M | $9M | · | · | |
| Capital Leases | $2M | $2M | $2M | · | · | |
| Total Liabilities | $11M | $8M | $10M | · | · | |
| Common Stock | $0 | $0 | $0 | · | · | |
| Paid-in Capital | $371M | $369M | $6M | · | · | |
| Retained Earnings | $-138M | $-119M | $-105M | · | · | |
| Stockholders' Equity | $232M | $250M | $-99M | · | · | |
| Liabilities + Equity | $243M | $258M | $116M | · | · | |
| Shares Outstanding | 33,446,315 | 33,432,555 | 2,203,620 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | · | $587.0K | $345.0K | |
| Operating Cash Flow | $-15M | $-14M | · | $-6M | $-8M | |
| CapEx | $2M | $676.0K | · | $52.0K | $164.0K | |
| Investing Cash Flow | $-933.0K | $-2M | · | $-52.0K | $-164.0K | |
| Financing Cash Flow | $13.0K | $158M | · | $76M | $50M | |
| Net Change in Cash | $-16M | $143M | · | $69M | $42M | |
| Taxes Paid | $1.0K | $0 | · | $0 | $4.0K | |
| Free Cash Flow | · | $-14M | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| ROA | -16.3% | -10.7% | · | · | · | |
| ROE | -17.1% | -11.1% | · | · | · | |
| ROIC | -9.4% | -6.2% | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Current Ratio | 25.1 | 38.0 | · | · | · | |
| Quick Ratio | 23.6 | 35.8 | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Book Value / Share | $6.95 | $7.48 | · | · | · | |
| Cash Flow / Share | · | $-0.68 | · | · | · | |
| Cash / Share | $6.67 | $7.15 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Market Cap | $745M | $866M | · | · | · | |
| P/B | 3.2 | 3.5 | · | · | · | |
| P / Tangible Book | 3.2 | 3.5 | · | · | · | |
| P / Cash Flow | · | -64.0 | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income | $-40M | $-29M |
| Diluted EPS | $-17.98 | $-16.31 |
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Current Ratio | 12.7 | · |
| Quick Ratio | 11.2 | · |
| Metric | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Free Cash Flow | $-33M | · |
Institutional owners (13F) 53 filers · $566.1M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
53
Value held
$566.1M
New positions
23
Exited positions
5
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 23 | 5 | 16 | 6 | · |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair. Change vs prior quarter not shown: filer coverage differs too much between these two quarters for a reliable comparison.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $178,550,064 | 8,021,117 | 31.54% | Shares |
| NEA Management Company, LLC | $164,552,620 | 7,392,301 | 29.07% | Shares |
| Sands Capital Alternatives, LLC | $55,650,267 | 2,500,012 | 9.83% | Shares |
| SAMSARA BIOCAPITAL, LLC | $46,967,554 | 2,109,953 | 8.30% | Shares |
| BlackRock, Inc. | $15,842,709 | 711,712 | 2.80% | Shares |
| Vestal Point Capital, LP | $14,914,200 | 670,000 | 2.63% | Shares |
| JPMORGAN CHASE & CO | $13,633,850 | 629,739 | 2.41% | Shares |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $12,243,000 | 550,000 | 2.16% | Shares |
| MILLENNIUM MANAGEMENT LLC | $11,291,541 | 507,257 | 1.99% | Shares |
| Aberdeen Group plc | $10,975,872 | 493,076 | 1.94% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $9,670,256 | 434,423 | 1.71% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $6,175,125 | 277,325 | 1.09% | Shares |
| FRANKLIN RESOURCES INC | $5,195,751 | 233,412 | 0.92% | Shares |
| Affinity Asset Advisors, LLC | $2,929,104 | 131,586 | 0.52% | Shares |
| STATE STREET CORP | $2,616,908 | 117,561 | 0.46% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,907,259 | 85,681 | 0.34% | Shares |
| NORTHERN TRUST CORP | $1,835,359 | 82,451 | 0.32% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,687,575 | 75,812 | 0.30% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $1,524,765 | 68,498 | 0.27% | Shares |
| Alyeska Investment Group, L.P. | $1,268,820 | 57,000 | 0.22% | Shares |
| TD Asset Management Inc | $1,059,131 | 47,580 | 0.19% | Shares |
| AMERIPRISE FINANCIAL INC | $1,016,570 | 45,668 | 0.18% | Shares |
| ALPS ADVISORS INC | $755,326 | 33,932 | 0.13% | Shares |
| Bank of New York Mellon Corp | $532,993 | 23,944 | 0.09% | Shares |
| Virtus Investment Advisers, LLC | $394,981 | 17,744 | 0.07% | Shares |
| Nuveen, LLC | $326,087 | 14,649 | 0.06% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $278,339 | 12,504 | 0.05% | Shares |
| RHUMBLINE ADVISERS | $263,641 | 11,844 | 0.05% | Shares |
| BANK OF AMERICA CORP /DE/ | $249,601 | 11,213 | 0.04% | Shares |
| DEUTSCHE BANK AG\ | $244,014 | 10,962 | 0.04% | Shares |
| WELLS FARGO & COMPANY/MN | $219,306 | 9,852 | 0.04% | Shares |
| MORGAN STANLEY | $198,582 | 8,921 | 0.04% | Shares |
| UBS Group AG | $176,856 | 7,945 | 0.03% | Shares |
| MetLife Investment Management, LLC | $155,508 | 6,986 | 0.03% | Shares |
| NEW YORK STATE COMMON RETIREMENT FUND | $120,204 | 5,400 | 0.02% | Shares |
| CITIGROUP INC | $115,529 | 5,190 | 0.02% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $113,593 | 5,103 | 0.02% | Shares |
| Vanguard Global Advisers, LLC | $102,997 | 4,627 | 0.02% | Shares |
| Police & Firemen's Retirement System of New Jersey | $72,746 | 3,268 | 0.01% | Shares |
| BARCLAYS PLC | $49,172 | 2,209 | 0.01% | Shares |
| STRS OHIO | $48,972 | 2,200 | 0.01% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $44,876 | 2,016 | 0.01% | Shares |
| FMR LLC | $33,323 | 1,497 | 0.01% | Shares |
| Legal & General Group Plc | $24,148 | 1,087 | 0.00% | Shares |
| Ameritas Investment Partners, Inc. | $22,394 | 1,006 | 0.00% | Shares |
| Russell Investments Group, Ltd. | $19,722 | 886 | 0.00% | Shares |
| Tower Research Capital LLC (TRC) | $16,695 | 750 | 0.00% | Shares |
| PRICE T ROWE ASSOCIATES INC /MD/ | $15,007 | 674,143 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $13,000 | 589 | 0.00% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3,406 | 153 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P., RA Capital Nexus Fund III, L.P. | Feb. 17, 2026 | 24.10% | Initial filing | Passive investment | SEC |
| New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang | Feb. 13, 2026 | 22.20% | Initial filing | Passive investment | SEC |
| Gilde Healthcare Holding B.V., Gilde Healthcare VG VI Management B.V., Cooperatieve Gilde Healthcare VG VI U.A., Manapouri B.V., Martemanshurk B.V. | Feb. 13, 2026 | 6.57% | Initial filing | Passive investment | SEC |
| Vensana Capital I GP, LLC, Vensana Capital I, L.P., Kirk Nielsen, Peter Justin Klein | Feb. 10, 2026 | 9.90% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 21 insiders · 5 officers · 10 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Patrick H. Mooney | Chief Executive Officer | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| Jean-Frederic Viret | Chief Financial Officer | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| Malik Y. Kahook | President, Chief Medical Officer, Executive Chair | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| James Robert Dennewill Jr. | Chief Operating Officer | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| Chetan Pratap Pujara | Chief R&D Officer | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| Bilal Arshad Khan | Director | Feb. 9, 2026 P | 251,427 | 2 | 0 | $2,160,000 |
| Geoffrey B Pardo | Director | Feb. 9, 2026 C | 2,187,513 | 1 | 0 | $5,000,000 |
| Ali Behbahani | Director | Feb. 9, 2026 C | 1,357,263 | 1 | 0 | $15,000,000 |
| Kirk Nielsen | Director | Feb. 9, 2026 C | 3,310,619 | 1 | 0 | $2,640,000 |
| Zachary Scheiner | Director | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| Elizabeth G. O'Farrell | Director | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| Habib J Dable | Director | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| Michael Dybbs | Director | Feb. 5, 2026 A | · | 0 | 0 | $0 |
| Rick Yang | 10% owner | Feb. 9, 2026 C | 6,035,038 | 1 | 0 | $15,000,000 |
| Carmen Chang | 10% owner | Feb. 9, 2026 C | 1,357,263 | 1 | 0 | $15,000,000 |
| Mohamad Makhzoumi | 10% owner | Feb. 9, 2026 C | 1,357,263 | 1 | 0 | $15,000,000 |
| Anthony A. Florence, Jr. | 10% owner | Feb. 9, 2026 C | 1,357,263 | 1 | 0 | $15,000,000 |
| Paul Walker | 10% owner | Feb. 9, 2026 C | 1,357,263 | 1 | 0 | $15,000,000 |
| Edward T. Mathers | 10% owner | Feb. 9, 2026 C | 6,035,038 | 1 | 0 | $15,000,000 |
| Forest Baskett | 10% owner | Feb. 9, 2026 C | 1,357,263 | 1 | 0 | $15,000,000 |
| Scott D. Sandell | 10% owner | Feb. 9, 2026 C | 1,357,263 | 1 | 0 | $15,000,000 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 37 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| EPHE · iShares Trust | 1.64% | 5,947,100 SH | Sept. 11, 2026 | Daily |
| IFGL · iShares Trust | 1.07% | 279,551 SH | Sept. 11, 2026 | Daily |
| BBC · ETFis Series Trust I | 0.82% | 16,855 NS | July 31, 2026 | N-PORT |
| VNQI · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.65% | 8,757,108 SH | Aug. 19, 2026 | Daily |
| REET · iShares Trust | 0.41% | 6,570,622 SH | Sept. 11, 2026 | Daily |
| ERET · iShares Trust | 0.35% | 15,473 SH | Sept. 11, 2026 | Daily |
| SCZ · iShares Trust | 0.20% | 8,398,148 SH | Sept. 11, 2026 | Daily |
| INTF · iShares Trust | 0.16% | 1,954,571 SH | Sept. 11, 2026 | Daily |
| GLOF · iShares Trust | 0.09% | 59,771 SH | Sept. 11, 2026 | Daily |
| IPAC · iShares Trust | 0.08% | 705,645 SH | Sept. 11, 2026 | Daily |
| IWC · iShares Trust | 0.07% | 37,601 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.07% | 150,351 SH | Sept. 11, 2026 | Daily |
| VPL · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.05% | 2,593,719 SH | Aug. 19, 2026 | Daily |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0.05% | 178,005 | Oct. 2, 2026 | Daily |
| PXF · Invesco Exchange-Traded Fund Trust … | 0.03% | 349,820 | Oct. 2, 2026 | Daily |
| IEFA · iShares Trust | 0.03% | 17,912,828 SH | Sept. 11, 2026 | Daily |
| EEMS · iShares, Inc. | 0.03% | 249,900 SH | Sept. 11, 2026 | Daily |
| IDEV · iShares Trust | 0.02% | 2,554,870 SH | Sept. 11, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.02% | 2,168 SH | Oct. 2, 2026 | Daily |
| VXUS · VANGUARD STAR FUNDS | 0.02% | 35,616,501 SH | Aug. 19, 2026 | Daily |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.02% | 5,665,750 SH | Aug. 19, 2026 | Daily |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.02% | 23,737,145 SH | Aug. 19, 2026 | Daily |
| VSGX · VANGUARD WORLD FUND | 0.02% | 483,037 SH | Aug. 19, 2026 | Daily |
| IXUS · iShares Trust | 0.02% | 3,283,148 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 71,664 SH | Sept. 11, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 1,968,824 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 63,570 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 8,207 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 252,096 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 5,291 NS | July 31, 2026 | N-PORT |
| IEMG · iShares, Inc. | 0.00% | 19,091,300 SH | Sept. 10, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 107,984 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 317,053 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,005 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 1,030 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 33,067 SH | Sept. 11, 2026 | Daily |
| ISCB · iShares Trust | · | 698 SH | Sept. 11, 2026 | Daily |
SGP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$42.00
+68.5%
5 50.0%
Strong Buy
4 40.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-03Mean target $44.00 +76.6%
← Below all targets
Current price $24.92
Low$37.00
Mean$44.00
High$62.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| SGP | · | · | · | · | 50.0% | · |
| SPTX | · | · | · | · | · | · |
| ANRO | $568M | -8.1 | · | · | -46.1% | · |
| ALMS | · | -3.4 | · | -1011.8% | -61.9% | · |
| APMD | · | · | · | · | · | · |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | · |
| COLL | $1.47B | 26.8 | 23.6% | 8.1% | 23.5% | 59.4% |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | · |
| AQST | $788M | -8.3 | -22.6% | -188.1% | 157.7% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026